A landmark study in iCurrent Neuropharmacology/i has uncovered a potential link between Glucagon-like bPeptide-1 (GLP-1) receptor agonists-commonly
Vous n'êtes pas connecté
A landmark study in iCurrent Neuropharmacology/i has uncovered a potential link between Glucagon-like bPeptide-1 (GLP-1) receptor agonists-commonly
A landmark study in iCurrent Neuropharmacology/i has uncovered a potential link between Glucagon-like bPeptide-1 (GLP-1) receptor agonists-commonly
FRIDAY, June 20, 2025 -- People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated...
FRIDAY, June 20, 2025 -- People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated...
bGlucagon-like peptide-1 receptor agonists/b (GLP-1RAs), a class of drugs commonly prescribed for type 2 diabetes, bimprove cardiovascular...
bGlucagon-like peptide-1 receptor agonists/b (GLP-1RAs), a class of drugs commonly prescribed for type 2 diabetes, bimprove cardiovascular...
New research, presented today at the European Academy of Neurology (EAN) Congress 2025, has uncovered a powerful link between nighttime heart rhythm...
New research, presented today at the European Academy of Neurology (EAN) Congress 2025, has uncovered a powerful link between nighttime heart rhythm...
Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are managed.
Beijing: A study from the University of Science and Technology of China, the Kunming Institute of Zoology of the Chinese Academy of Sciences, and the...
Beijing: A study from the University of Science and Technology of China, the Kunming Institute of Zoology of the Chinese Academy of Sciences, and the...